 |
fully human IgG2 monoclonal antibody that binds insulin receptors |
|---|---|
| Trade Name | |
| Orphan Indication | Congenital hyperinsulinism |
| USA Market Approval | USA |
| USA Designation Date | 2015-06-09 00:00:00 |
| Sponsor | XOMA (US) LLC;2910 Seventh St.;Berkeley, California, 94710 |
